June 2020

Column

Editor's Page

06/17/2020

Winston Wong, PharmD, Editor-in-Chief

Champions for value-based care seek to evolve the health care system to a model that emphasizes the importance of keeping people healthy, rewards physicians for coordinating care, provides the appropriate care for...

...

06/17/2020

Journal of Clinical Pathways

Trending From ACCC

Advancing Cancer Clinical Trials in the “New Normal”

06/17/2020

JCP Editors

As cancer programs and practices across the country transition into the chronic-phase landscape of the COVID-19 pandemic, the Association of Community Cancer Centers (ACCC) continues to respond to the needs of its...

As...

06/17/2020

Journal of Clinical Pathways

Clinical Pathways GPS

Where Health Systems Are in the Shift to Value: Four Categories

06/17/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

One could make the argument that there are four situational categories under which all health systems now fall on the journey toward more value-based care and away from the fee-for-service model. Assisting health...

One...

06/17/2020

Journal of Clinical Pathways

Pharma Insights

Journeying Through the Past, Present, and Future of Medicare Part D

06/17/2020

Andrew Cournoyer, RPh, MBA

Charline Shan, RPh, MPh

Larry Blandford, PharmD—Column Editor

This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors,...

This...

06/17/2020

Journal of Clinical Pathways

Engaging Payers

Partnership in Value-Based Care: Becoming and Finding Good Teammates

05/19/2020

Lili Brillstein, MPH—Column Editor

Value-based care is a whole-person philosophy that relies on the diverse expertise of various stakeholders and the ability of each and all to effectively collaborate to deliver the most effective and comprehensive...

...

05/19/2020

Journal of Clinical Pathways

Department

Pathways in Practice

Tumor-Agnostic Testing in a Non-Small Cell Lung Cancer Pathway

06/17/2020

JCP Editors

In this journal section, we speak with cancer care practitioners about their clinical pathways and pathways programs being used in their practice, including how they are being applied in a particular disease state...

In...

06/17/2020

Journal of Clinical Pathways

Feature

From the Field

Insights Gained From a Pilot Study Investigating Early Survivorship Care Interventions

06/17/2020

Deborah Christensen, MSN, APRN

Bonita S Agee, PhD

Cheryl Bellomo, MSN, RN, OCN

Abstract: Intermountain Healthcare, a Utah-based, not-for-profit organization, co-sponsored a pilot study to evaluate potential benefits of early survivorship care by offering a treatment summary and survivorship...

...

06/17/2020

Journal of Clinical Pathways

Perspectives

COVID-19 Pandemic Vindicates the ISPOR Value Flower

06/17/2020

Jason Shafrin, PhD

Kathy Lang, PhD

Ross Maclean, MD

Abstract: What is the right price for a new treatment for COVID-19? One common approach—which is frequently used worldwide and in the United States by the Institute of Clinical and Economic Review—measures treatment...

...

06/17/2020

Journal of Clinical Pathways

Current Issue

August 2024

Volume 10

Issue 4

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

June 2020

Column

Department

Feature

Current Issue

Special Reports

Subscribe

Volume 6

Specialties

Events

Year Round Education

HMP Global Products